Combination therapy with metformin and fenofibrate for insulin resistance in obesity (vol 39, pg 1876, 2011)

被引：0
|
作者：
Li, X-M [1 ]
Li, Y. [3 ]
Zhang, N-N [1 ]
Xie, Y-H [4 ]
Shi, Y-Q [2 ]
机构：
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Endocrinol, Xian 710032, Peoples R China
[2] Fourth Mil Med Univ, Xijing Hosp, Dept Gastroenterol, Xian 710032, Peoples R China
[3] Fourth Mil Med Univ, Stomatol Coll, Dept Anaesthesiol, Xian 710032, Peoples R China
[4] Fourth Mil Med Univ, Tangdu Hosp, Dept Resp Med, Xian 710032, Peoples R China
来源：
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH | 2012年 / 40卷 / 03期
关键词：
D O I：
10.1177/147323001204000342
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1216 / 1216
页数：1
相关论文
共 50 条
  • [31] Elevated Hypothalamic TCPTP in Obesity Contributes to Cellular Leptin Resistance (vol 14, pg 684, 2011)
    Loh, Kim
    Fukushima, Atsushi
    Zhang, Xinmei
    Galic, Sandra
    Briggs, Dana
    Enriori, Pablo J.
    Simonds, Stephanie
    Wiede, Florian
    Reichenbach, Alexander
    Hauser, Christine
    Sims, Natalie A.
    Bence, Kendra K.
    Zhang, Sheng
    Zhang, Zhong-Yin
    Kahn, Barbara B.
    Neel, Benjamin G.
    Andrews, Zane B.
    Cowley, Michael A.
    Tiganis, Tony
    CELL METABOLISM, 2022, 34 (11) : 1892 - 1892
  • [32] Childhood Obesity and the Built Environment (vol 39, pg 133, 2010)
    Razani, Nooshin
    PEDIATRIC ANNALS, 2010, 39 (06): : 331 - 331
  • [33] Incidence and mechanisms of resistance to the combination of amoxicillin and clavulanic acid in Escherichia coli (vol 39, pg 2478, 1995)
    Stapleton, P
    Wu, PJ
    King, A
    Shannon, K
    French, G
    Phillips, I
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) : 2773 - 2773
  • [34] Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and rosiglitazone or insulin and acarbose in type 2 diabetes
    Hamiyet Yilmaz
    Alptekin Gursoy
    Mustafa Sahin
    Nilgun Guvener Demirag
    Acta Diabetologica, 2007, 44 : 187 - 192
  • [35] Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and rosiglitazone or insulin and acarbose in type 2 diabetes
    Yilmaz, Hamiyet
    Gursoy, Alptekin
    Sahin, Mustafa
    Demirag, Nilgun Guvener
    ACTA DIABETOLOGICA, 2007, 44 (04) : 187 - 192
  • [36] Corticosteroid therapy for patients in septic shock: Some progress in a difficult decision (vol 39, pg 571, 2011)
    Sprung, S. L.
    Brezis, M.
    Goodman, S.
    CRITICAL CARE MEDICINE, 2011, 39 (05) : 1247 - 1247
  • [37] Obstructive Sleep Apnea, Insulin Resistance, and Steatohepatitis in Severe Obesity(vol 179, pg 228, 2009)
    Polotsky, Vsevolod Y.
    Patil, Susheel P.
    Kamsheh, Sarah
    Guzman-Velez, Edmarie
    Schwartz, Alan R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 180 (09) : 910 - 911
  • [38] Mechanisms of macrophage activation in obesity-induced insulin resistance (vol 4, pg 619, 2008)
    Odegaard, Justin I.
    Chawla, Ajay
    NATURE REVIEWS ENDOCRINOLOGY, 2009, 5 (05) : 234 - 234
  • [39] Cannabis use in relation to obesity and insulin resistance in the inuit population (vol 23, pg 290, 2015)
    Ngueta, Gerard
    Belanger, Richard E.
    Laouan-Sidi, Elhadji A.
    Lucas, Michel
    OBESITY, 2015, 23 (10) : 2131 - 2131
  • [40] Synergistic Improvement in Insulin Resistance with a Combination of Fenofibrate and Rosiglitazone in Obese Type 2 Diabetic Mice
    Choi, Woon-Seok
    Lee, Jung-Jin
    Kim, Yohan
    Kim, In-Su
    Zhang, Wei-Yun
    Myung, Chang-Seon
    ARCHIVES OF PHARMACAL RESEARCH, 2011, 34 (04) : 615 - 624
12345